Salt CompositionGliclazide 1mg + Metformin 500mg + Voglibose 0.2mg
You Searched
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
Customers also bought
More About Gvos M 0.2/500/1mg Tablet 10s
Side Effects
Side effects of Gvos M Tablet The majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you�re worried about them Common side effects of Gvos MNausea Hypoglycemia (low blood glucose level)Abdominal pain Constipation
How to use
How to use Gvos M Tablet Follow your doctor's guidance regarding the dose and duration of this medication. Ingest it without breaking or crushing. Do not chew, crush or break it. Gvos M 0.2mg/500mg/1mg Tablet is to be taken with food.
How it works
How Gvos M Tablet works Gvos M 0.2mg/500mg/1mg Tablet is a combination of three antidiabetic medicines:.
Unsafe: Avoid consuming alcohol with Gvos M 0.2mg/500mg/1mg Tablet as it is deemed unsafe.
Gvos M 0.2mg/500mg/1mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Doctor consultation is advised.
Gvos M 0.2mg/500mg/1mg Tablet should be used with caution during breastfeeding. Breastfeeding should be held until the treatment of the mother is completed and the drug is eliminated from her body.
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
Gvos M 0.2mg/500mg/1mg Tablet should be used with caution in patients with kidney disease. Dose adjustment of Gvos M 0.2mg/500mg/1mg Tablet may be needed. Doctor consultation is advised.Use of Gvos M 0.2mg/500mg/1mg Tablet is, however, not recommended in patients with severe kidney disease. Regular monitoring of kidney function test is advisable while you are taking this medicine.
Gvos M 0.2mg/500mg/1mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Gvos M 0.2mg/500mg/1mg Tablet may be needed. Doctor consultation is advised.Gvos M 0.2mg/500mg/1mg Tablet is generally started with low dose in patients with mild to moderate liver disease and its use is not recommended in patients with severe liver disease.
Manufacturer Address
H.No.16-310/6/1/1Asaleem Nagar, Musharambagh, Hyderabad-2, Telangana
References
Glimepiride (08 Apr. 2019)
Metformin hydrochloride (08 Apr. 2019)
Dabhi AS, Bhatt NR, Shah MJ. Voglibose: An Alpha Glucosidase Inhibitor. J Clin Diagn Res. 2013;7(12):3023-7 (08 Apr. 2019)
Glimepiride+Metformin+Voglibose (25 Oct. 2021)
Metformin Hydrochloride (Prolonged Release), Voglibose & Glimepiride (28th Sept. 2023)
Disclaimer
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.
